MeSH tree: C04.588.805.377
Imagine you're getting out of the shower one morning and notice a mole on your thigh that you've never seen before. It's reddish-brown, bumpy and surprisingly large. Is it a benign mole, or is it melanoma?
Sep 3, 2026
0
2
Cancers actively remodel their surrounding cells and tissues to create a microenvironment that favors their growth, survival and spread. Melanoma, a cancer of the pigment-producing melanocytes of the skin, is one of the most ...
Sep 1, 2026
0
9
Scroll through social media and you will encounter a strange vocabulary for an old impulse: "tanmaxxing," "UV chasing" and "SPF shunning." In some corners of the internet, sunscreen is described as toxic, while a "natural" ...
Aug 27, 2026
0
7
Researchers have created one of the most detailed maps to date of how white blood cells called B cells develop and behave inside melanoma tumors, a type of skin cancer. The study, led by King's College London and published ...
Aug 25, 2026
0
4
Cornell researchers successfully ramped up the body's own immune response to fight melanoma at the tail end of targeted cancer therapy, when tumors commonly become resistant to these therapies and leave behind residual cancer ...
Aug 24, 2026
0
6
US drugmakers Merck and Moderna said Wednesday a personalized cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a "breakthrough."
Aug 19, 2026
0
24
Cancer patients often face more than the disease itself. Their treatment is frequently complicated by infections and other health conditions, meaning they may need to take several different medications at once. As the number ...
Aug 18, 2026
0
9
Of more than 500 occupations in the United States, flight attendants and pilots have the highest and second-highest proportions of radiation-related cancer deaths, a new study has found.
Aug 17, 2026
0
27
In a first-of-its-kind study by King's College London, researchers have linked changes in two major types of immune cells in blood to different survival outcomes for patients with melanoma. Melanoma, the fifth most common ...
Aug 11, 2026
0
5
New research from the University of Texas at Arlington helps explain a longstanding puzzle in melanoma treatment: why continuous targeted therapy performed better than planned on-and-off treatment schedules in clinical trials, ...
Aug 10, 2026
0
6
